Inventor
Michael George Natchus
Inventor
Alpharetta, GA, US
Overview
Patents· 41 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds7%
Y02ATechnologies for adaptation to climate change5%
C07JSteroids4%
Y02PClimate change mitigation technologies in the production or processing of goods2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07KPeptides1%
LOC321%
PatentTitleYear
10,716,795Steroid analogues for neuroprotection202010,632,120Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction202010,487,109Progesterone phosphate analogs and uses related thereto201910,336,787Progesterone analogs and uses related thereto201910,016,408Chemokine CXCR4 receptor modulators and uses related thereto20189,802,978'Progesterone phosphate analogs and uses related thereto'20179,545,403'Chemokine CXCR4 receptor modulators and uses related thereto'20179,527,881'Steroid analogues for neuroprotection'20169,314,468'Chemokine receptor modulators'20169,205,085'Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction'20158,969,381'Chemokine CXCR4 receptor modulators and used related thereto'2015D0685387'Graphical user interface for a display screen or a portion thereof'20138,338,448'Chemokine receptor modulators'20127,189,856'Non-peptide somatostatin receptor ligands'20076,949,545'Heterocyclic side chain containing, n-substituted metalloprotease inhibitors'20056,919,346'Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity'20056,872,742'Substituted cyclic amine metalloprotease inhibitors'20056,858,628'Substituted cyclic amine metalloprotease inhibitors'20056,852,751'Difluorobutyric acid metalloprotease inhibitors'20056,790,846'Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity'20046,787,555'Triazole compounds useful in treating diseases associated with unwanted cytokine activity'20046,762,198'Dihetero-substituted metalloprotease inhibitors'20046,730,668'6,7-dihydro-5H-pyrazolo1,2-apyrazol-1-ones which control inflammatory cytokines'20046,727,364'Triazole compounds useful in treating diseases associated with unwanted cytokine activity'20046,696,456'Beta disubstituted metalloprotease inhibitors'20046,677,337'1,2-dihydropyrazol-3-ones which controls inflammatory cytokines'20046,569,855'Substituted cyclic amine metalloprotease inhibitors'20036,566,381'Hetero-substituted metalloprotease inhibitors'20036,545,038'Heterocyclic metalloprotease inhibitors'20036,469,000'1,3-diheterocyclic metalloprotease inhibitors'20026,465,474'1,3-diheterocyclic metalloprotease inhibitors'20026,417,219'Hetero-substituted cyclic amine metalloprotease inhibitors'20026,399,598'Diheterocyclic metalloprotease inhibitors'20026,329,418'Substituted pyrrolidine hydroxamate metalloprotease inhibitors'20016,218,389'Acyclic metalloprotease inhibitors'20016,197,770'Alkenyl- and alkynl-containing metalloprotease inhibitors'20016,166,005'Heterocyclic metalloprotease inhibitors'20006,150,370'1,3-diheterocyclic metalloprotease inhibitors'20006,121,258'1,5-heterocyclic metalloprotease inhibitors'20006,015,912'Spirocyclic containing hydroxamic acids useful as metalloprotease inhibitors'20005,672,598'Lactam-containing hydroxamic acids'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2005Patents assigned to PROCTER & GAMBLE (27)· patent assignee history
1997Based in Cincinnati, OH, US· patent location history
2000–2005Based in Glendale, OH, US· patent location history
2004–2020Based in Alpharetta, GA, US· patent location history
2007–2016Patents assigned to NATCHUS MICHAEL G (5)· patent assignee history
2007–2016Patents assigned to LOCKWOOD MARK A (3)· patent assignee history
2012–2016Patents assigned to ALTIRIS THERAPEUTICS INC (2)· patent assignee history
2013–2020Patents assigned to UNIV EMORY (11)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROCTER & GAMBLE | 27 | 1997–2005 |
| UNIV EMORY | 11 | 2013–2020 |
| NATCHUS MICHAEL Gself | 5 | 2007–2016 |
| LOCKWOOD MARK A | 3 | 2007–2016 |
| ALTIRIS THERAPEUTICS INC | 2 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Alpharetta, Georgia, US | 22 | 2004–2020 |
| Glendale, OH, US | 18 | 2000–2005 |
| Cincinnati, OH, US | 1 | 1997 |